Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004665317 | SCV005163539 | uncertain significance | not specified | 2024-06-19 | criteria provided, single submitter | clinical testing | The c.442T>C (p.F148L) alteration is located in exon 3 (coding exon 3) of the RAET1L gene. This alteration results from a T to C substitution at nucleotide position 442, causing the phenylalanine (F) at amino acid position 148 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |